Shield as signal: lipopolysaccharides and the evolution of immunity to gram-negative bacteria.
Munford
Robert S
RS
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Robert.munford@utsouthwestern.edu
Varley
Alan W
AW
D000215:Acylation; D000818:Animals; D005075:Biological Evolution; D002265:Carboxylic Ester Hydrolases / Q000502:physiology; D006090:Gram-Negative Bacteria / Q000276:immunology* / Q000472:pathogenicity / Q000502:physiology; D016905:Gram-Negative Bacterial Infections / Q000276:immunology* / Q000503:physiopathology; D006801:Humans; D006868:Hydrolysis; D007113:Immunity, Innate / Q000276:immunology* / Q000502:physiology; D018928:Immunity, Mucosal / Q000276:immunology / Q000502:physiology; D008050:Lipid A / Q000276:immunology / Q000502:physiology*; D008070:Lipopolysaccharides / Q000276:immunology*; D051197:Toll-Like Receptor 4 / Q000276:immunology / Q000502:physiology
D008050:Lipid A; D008070:Lipopolysaccharides; D051197:Toll-Like Receptor 4; D002265:Carboxylic Ester Hydrolases; C048964:acyloxyacyl hydrolase